Figure S6 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity
Year: 2024
Type: other
Abstract: Fig. S6. Dose-dependent effect of ACY-1215 and tubastatin-A on the biochemical activity of the HDACs and SIRTs.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4399771940
